biomarkers « Science and Enterprise

Sensor Patch Tracks Chemical, Physical Vital Signs

By Alan, on May 24th, 2016%

Chem-Phys patch demonstrated by co-author Amay Bandodkar (University of California, San Diego)

24 May 2016. Engineers at University of California in San Diego developed a patch device worn on the skin with sensors that measure chemical indicators as well as physical vital signs. The UC-San Diego team that designed the device published its . . . → Read More: Sensor Patch Tracks Chemical, Physical Vital Signs

Venture Firm Funding Univ. Blood Diagnostics Technology

By Alan, on May 23rd, 2016%

(Public Domain Pictures/Pixabay)

23 May 2016. A life sciences venture capital company is funding development of a technology at an Israeli research lab using DNA from blood tests to diagnose a range of diseases. Aurum Ventures is providing $1.2 million to Hebrew University of Jerusalem, through its technology transfer affiliate Yissum Research Development . . . → Read More: Venture Firm Funding Univ. Blood Diagnostics Technology

Tropical Disease Diagnostics Now on Market

By Alan, on April 12th, 2016%

The Carter Center, founded by former U.S. president Jimmy Carter, has been instrumental in eradicating river blindness in Africa. (share.america.gov)

12 April 2016. PATH research institute and medical test developer Standard Diagnostics are making available tests for the tropical diseases onchocerciasis and lymphatic filariasis. The rapid, point-of-care tests are designed to help health . . . → Read More: Tropical Disease Diagnostics Now on Market

Cancer Diagnostics Company Raises $12.3M in IPO

By Alan, on March 18th, 2016%

(A. Kotok)

18 March 2016. VolitionRx, a developer of blood tests that screen for cancer and other disorders, is raising some $12.3 million in its initial public stock offering. The Namur, Belgium company, listed on the New York Stock Exchange under the symbol VNRX, issued about 3.8 million shares of common stock priced . . . → Read More: Cancer Diagnostics Company Raises $12.3M in IPO

Biomarker Profiles Shown to Improve Ovarian Cancer Survival

By Alan, on March 14th, 2016%

(National Heart, Lung, and Blood Institute, NIH)

14 March 2016. A clinical trial of people with ovarian cancer shows patients receiving treatments matching their particular molecular profiles survived an average of 9 months longer than those receiving one or more drugs not matching their biomarkers. Results of the study, conducted by Caris Life . . . → Read More: Biomarker Profiles Shown to Improve Ovarian Cancer Survival

Study to Develop Simple, Standard TBI Test Process

By Alan, on March 9th, 2016%

(Flickr)

9 March 2016. An industry, academic, and medical center research team is beginning a study to better diagnose traumatic brain injury with multiple testing methods. The project is an undertaking of medical device maker Abbott, Hennepin County Medical Center in Minneapolis, and University of Minnesota medical school, also in Minneapolis.

The initiative . . . → Read More: Study to Develop Simple, Standard TBI Test Process

NSF Grant Funds Biosensing Laser Research

By Alan, on February 9th, 2016%

Yuze “Alice” Sun (University of Texas, Arlington)

9 February 2016. An engineering professor at University of Texas in Arlington received a grant from National Science Foundation for research on lasers with fluid samples to detect indicators of disease. Yuze Sun, known as Alice, is the recipient of a $500,000 Faculty Early Career Development . . . → Read More: NSF Grant Funds Biosensing Laser Research

Test IDs Mesothelioma Years Before Symptoms Appear

By Alan, on February 5th, 2016%

(National Cancer Institute)

5 February 2016. A company spun-off from Purdue University designed a test that in a recent study detects cases of mesothelioma, a form of lung cancer, several years before symptoms develop. Results of the study conducted by MorNuCo Laboratories in West Lafayette, Indiana appear in the 22 January issue of . . . → Read More: Test IDs Mesothelioma Years Before Symptoms Appear

Phillips, Banyan Partner on Point-of-Care Concussion Test

By Alan, on January 7th, 2016%

Minicare blood analysis device (Royal Phillips)

7 January 2016. A collaboration between electronics manufacturer Royal Phillips and medical diagnostics company Banyan Biomarkers Inc. is developing a handheld blood test for concussions and other mild traumatic brain injuries. Financial and intellectual property aspects of the partnership were not disclosed.

Traumatic brain injury is caused . . . → Read More: Phillips, Banyan Partner on Point-of-Care Concussion Test

Penn, Epic Sciences Partner on Liquid Biopsies

By Alan, on November 13th, 2015%

(Public Domain Pictures/Pixabay)

13 November 2015. University of Pennsylvania’s medical school plans to apply liquid biopsy technology developed by Epic Sciences to gain a more detailed understanding of different cancers for individual patient therapies. Financial terms of the agreement between the university and the San Diego biotechnology company were not disclosed.

Epic Sciences’s . . . → Read More: Penn, Epic Sciences Partner on Liquid Biopsies

Subscribe for email alerts

Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Like us on Facebook

Specials

Guest Posts

Please share Science & Enterprise